Abstract

Anil Kamat is a recognized clinical leader in hematology, with extensive experience in both clinical and manufacturing contexts. He is head of clinical development at Immuneel Therapeutics, based in Bengaluru, India, and serves as a consultant hematologist for the UK National Health Service. Dr Kamat is a member and contributor to several societies, including the International Society for Cell and Gene Therapy, the American Society of Hematology, and the European Group for Blood and Marrow Transplantation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.